Search results

NICE has developed a medtech innovation briefing (MIB) on HealthVCF for detecting vertebral compression fractures on CT scans .

Result type

Medtech innovation briefing

Published

13 July 2021

NICE advice is a support service for pharmaceutical and healthtech companies seeking to enter the NHS market.

Evidence-based recommendations on etelcalcetide (Parsabiv) for treating secondary hyperparathyroidism in adults with chronic kidney disease on haemodialysis.

Result type

Technology appraisal guidance

Published

28 June 2017

Evidence-based recommendations on aflibercept (Eylea) for treating sight problems caused by diabetic macular oedema in adults.

Result type

Technology appraisal guidance

Published

22 July 2015

Evidence-based recommendations on eribulin (Halaven) for treating locally advanced or metastatic (secondary) breast cancer in adults who have had only 1 course of chemotherapy.

Result type

Technology appraisal guidance

Published

28 March 2018

NICE has developed a medtech innovation briefing (MIB) on OCS Heart system for heart transplant .

Result type

Medtech innovation briefing

Published

29 November 2016

NICE has developed a medtech innovation briefing (MIB) on point-of-care and home faecal calprotectin tests for monitoring treatment response in inflammatory bowel disease .

Result type

Medtech innovation briefing

Published

4 December 2017

NICE has developed a medtech innovation briefing (MIB) on PROPEL sinus implants for maintaining sinus patency after surgery .

Result type

Medtech innovation briefing

Published

9 February 2021

Evidence-based recommendations on mosunetuzumab (Lunsumio) for relapsed or refractory follicular lymphoma in adults.

Result type

Technology appraisal guidance

Published

31 May 2023

Evidence-based recommendations on aripiprazole for treating schizophrenia in young people aged 15 to 17.

Result type

Technology appraisal guidance

Published

26 January 2011

Evidence-based recommendations on arsenic trioxide (Trisenox) for treating acute promyelocytic leukaemia in adults.

Result type

Technology appraisal guidance

Published

13 June 2018

healthcare sectors in order to adopt best practice rapidly and develop innovative solutions. The services we offer include: A chronic...

Result type

Shared learning

Last updated

10 August 2020

NICE's HTA Lab enables us to develop creative solutions to complex problems in health technology assessment.

Evidence-based recommendations on vortioxetine (Brintellix) for treating major depressive episodes in adults.

Result type

Technology appraisal guidance

Published

25 November 2015

Evidence-based recommendations on trastuzumab deruxtecan (Enhertu) for treating HER2-positive unresectable or metastatic breast cancer after 1 or more anti-HER2 treatments in adults.

Result type

Technology appraisal guidance

Published

1 February 2023